Name | 4-(5,7-dimethoxy-6-(3-methylbut-2-en-1-yl)-2H-chromen-3-yl)benzene-1,3-diol |
---|---|
Synonyms |
4-[(R)-5,7-Dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl]-benzene-1,3-diol
4-((R)-5,7-Dimethoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-3-yl)-benzene-1,3-diol 1,3-Benzenediol, 4-[5,7-dimethoxy-6-(3-methyl-2-buten-1-yl)-2H-1-benzopyran-3-yl]- 4-[5,7-Dimethoxy-6-(3-methyl-2-buten-1-yl)-2H-chromen-3-yl]-1,3-benzenediol |
Description | Dehydroglyasperin D inhibits rat and human Aldose Reductase (AR) (IC50: 62.4 μM and 176.2 μM respectively). Dehydroglyasperin D has anti-obesity, antioxidant effects. Dehydroglyasperin D shows anti-inflammatory activity by inhibiting COX-2 expression and the MLK3 signaling pathway. Dehydroglyasperin D also inhibits melanin synthesis. Dehydroglyasperin D is a prenylated flavonoid that can be isolated from Glycyrrhiza uralensi[1][2][3]. |
---|---|
Related Catalog | |
Target |
COX-2[1] |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 557.9±50.0 °C at 760 mmHg |
Molecular Formula | C22H24O5 |
Molecular Weight | 368.42 |
Flash Point | 291.2±30.1 °C |
Exact Mass | 368.162384 |
PSA | 68.15000 |
LogP | 6.18 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.605 |
Hazard Codes | Xi |
---|